Xenon Pharmaceuticals Stock

Xenon Pharmaceuticals Employees 2025

Xenon Pharmaceuticals Employees

122

Ticker

XENE

ISIN

CA98420N1050

WKN

A12ETN

In 2025, Xenon Pharmaceuticals employed 122 people, a 0% change from the 122 number of employees in the previous year.

Xenon Pharmaceuticals Aktienanalyse

What does Xenon Pharmaceuticals do?

Xenon Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of innovative therapies for rare diseases. It was founded in 1996 and is headquartered in Burnaby, British Columbia, Canada, with additional offices in the United States and Europe. The company has become a leading biotech company in the industry and focuses on identifying and developing treatments for rare diseases through its proprietary platform called Extreme Genetics. Xenon Pharmaceuticals has a wide pipeline of clinical candidates targeting diseases such as ichthyosis, X-linked adrenoleukodystrophy, pain disorders, and epilepsy. It collaborates with pharmaceutical companies to utilize its platform technology and expertise in the research of rare diseases. Its key drug candidate is XEN496 for the treatment of epilepsy. Overall, Xenon Pharmaceuticals plays a significant role in the biotech industry and continues to make progress in developing innovative therapies for rare diseases. Xenon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Xenon Pharmaceuticals's Employee Base

Xenon Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Xenon Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Xenon Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Xenon Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Xenon Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Xenon Pharmaceuticals stock

How many employees does Xenon Pharmaceuticals have this year?

Xenon Pharmaceuticals has 122 undefined employees this year.

How many employees did Xenon Pharmaceuticals have compared to the previous year?

Compared to the previous year, Xenon Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Xenon Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Xenon Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Xenon Pharmaceuticals?

The number of employees can also have an impact on investors of Xenon Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Xenon Pharmaceuticals affect the company?

An increase in equity of Xenon Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Xenon Pharmaceuticals's equity affect the company?

A reduction in equity of Xenon Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Xenon Pharmaceuticals?

Some factors that can influence the equity of Xenon Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Xenon Pharmaceuticals so important for investors?

The equity of Xenon Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Xenon Pharmaceuticals influence the company?

The number of employees at Xenon Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Xenon Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Xenon Pharmaceuticals has changed by 0.

How many employees does Xenon Pharmaceuticals currently have?

Xenon Pharmaceuticals currently has 122 undefined employees.

Why is the number of employees important for investors of Xenon Pharmaceuticals?

The number of employees is important for investors of Xenon Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Xenon Pharmaceuticals take to change the number of employees?

To change the number of employees, Xenon Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Xenon Pharmaceuticals pay?

Over the past 12 months, Xenon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xenon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Xenon Pharmaceuticals?

The current dividend yield of Xenon Pharmaceuticals is .

When does Xenon Pharmaceuticals pay dividends?

Xenon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xenon Pharmaceuticals?

Xenon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Xenon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xenon Pharmaceuticals located?

Xenon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xenon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xenon Pharmaceuticals from 8/1/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2025.

When did Xenon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/1/2025.

What was the dividend of Xenon Pharmaceuticals in the year 2024?

In the year 2024, Xenon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Xenon Pharmaceuticals pay out the dividend?

The dividends of Xenon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Xenon Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Xenon Pharmaceuticals

Our stock analysis for Xenon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xenon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.